We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The agency said sponsors intending to market multiple dose combinations should “avoid marketing excessive numbers of combinations whose components exert similar blood pressure effects.” Read More
CMS Administrator Seema Verma said value-based payment “is not a panacea…[but] it is an important part of our strategy to lower drug prices.” Read More
An audit by New York State Comptroller Thomas DiNapoli found that the state’s treatment programs didn’t adequately monitor patients with opioid use disorders to ensure they didn’t receive opioid prescriptions elsewhere. Read More
A federal lawsuit accuses Gilead of deliberately keeping a safer version of its HIV drug Tenofovir disoproxil fumarate (TDF) off the market until patent exclusivity ends for the original. Read More
The legislation would “increase prescription drug competition in U.S. markets, driving down prices and improving the quality of life for patients across the country,” the letter states. Read More
“Facilities using this processing technique to manufacture sterile drug products were a logical starting place because of the significant impacts on patient safety… Read More